The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).

Detalhes bibliográficos
Main Authors:	Kaltsas, G, Papadogias, D, Grossman, AB
Formato:	Journal article
Idioma:	English
Publicado em:	2004

Registos relacionados

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Por: Chrisoulidou, A, et al.
Publicado em: (2007)

The clinical genetics of phaeochromocytoma and paraganglioma
Por: P. T. Kavinga Gunawardane, et al.

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Por: Bomanji, J, et al.
Publicado em: (1993)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
Por: Bouloux, P, et al.
Publicado em: (1986)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
Por: Mukherjee, J, et al.
Publicado em: (2001)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
Por: Foo, S.H., et al.
Publicado em: (2010)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
Por: Srirangalingam, U, et al.
Publicado em: (2008)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
Por: Kaltsas, G, et al.
Publicado em: (2005)

Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
Por: U. Srirangalingam, et al.
Publicado em: (2017-01-01)

Using parenclitic networks on phaeochromocytoma and paraganglioma tumours provides novel insights on global DNA methylation
Por: Dimitria Brempou, et al.
Publicado em: (2024-12-01)

Personalized diagnostics of chromaffin tumors (pheochromocytoma, paraganglioma) in oncoendocrinology
Por: Pavel O. Rumyantsev, et al.
Publicado em: (2018-07-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
Por: Sofia Maria Lider Burciulescu, et al.
Publicado em: (2023-02-01)

A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
Por: Christopher S. Boot
Publicado em: (2023-09-01)

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
Por: Srirangalingam, U, et al.
Publicado em: (2009)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
Por: Kaltsas, G, et al.
Publicado em: (2004)

Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension.
Por: Frankton, S, et al.
Publicado em: (2009)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Por: Astuti, D, et al.
Publicado em: (2003)

Predictors of outcome in phaeochromocytomas and paragangliomas [version 1; referees: 3 approved]
Por: Marlo Nicolas, et al.
Publicado em: (2017-12-01)

A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
Por: Prodromos Chatzikyriakou, et al.
Publicado em: (2023-12-01)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
Por: Druce, MR, et al.
Publicado em: (2009)

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma
Por: Samsudin, Intan Nureslyna, et al.
Publicado em: (2018)

Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
Por: Andrea Luchetti, et al.
Publicado em: (2015-01-01)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
Por: Poplawski NK, et al.
Publicado em: (2012-04-01)

The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
Por: Sheaves, R, et al.
Publicado em: (1995)

Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
Por: Nölting, S, et al.
Publicado em: (2012)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
Por: Calum Urquhart, et al.
Publicado em: (2022-11-01)

Unilateral Sporadic Carotid Paraganglioma
Por: Sushil G. Kachewar, et al.
Publicado em: (2011-12-01)

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
Por: Dahia, P, et al.
Publicado em: (1997)

Malignant pituitary tumours.
Por: Kaltsas, G, et al.
Publicado em: (1998)

Rare presentation of collapse and cardiomyopathy in phaeochromocytoma
Por: Rajiv Singh, et al.
Publicado em: (2021-05-01)

Phaeochromocytoma Crisis: Two Cases of Undiagnosed Phaeochromocytoma Presenting after Elective Nonrelated Surgical Procedures
Por: P. C. Johnston, et al.
Publicado em: (2013-01-01)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
Por: Wong Nora, et al.
Publicado em: (2006-01-01)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
Por: Nastos, K, et al.
Publicado em: (2017)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
Por: Lawrence, J, et al.
Publicado em: (2004)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
Por: Kaltsas, G, et al.
Publicado em: (2002)

Intracerebral haemorrhage: A rare presentation of phaeochromocytoma
Por: Swati Chhikara, et al.
Publicado em: (2021-01-01)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
Por: Kaltsas, G, et al.
Publicado em: (2003)

A Rare Case: Sporadic Bladder Paraganglioma
Por: Hakan Ercil, et al.
Publicado em: (2013-08-01)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
Por: David J. Pinato, et al.
Publicado em: (2017-11-01)

MIBG scans for phaeochromocytoma: time to abandon the technique?
Por: Grossman, A, et al.
Publicado em: (2009)